GILEAD SCIENCES, INC. — Investor Relations & Filings
Filings indexed
1,975
across all filing types
Latest filing
2026-05-20
Regulatory Filings
Country
US
United States of America
Listing
US
GILD
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-20 | English | |
| 424B5 | 2026-05-18 | English | |
| FWP | 2026-05-14 | English | |
| 424B5 | 2026-05-14 | English | |
| Regulatory Filings 2026 | 2026-05-08 | English | |
| S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46691604 | FORM 8-K | 2026-05-20 | English | ||
| 46459832 | 424B5 | 2026-05-18 | English | ||
| 46273906 | FWP | 2026-05-14 | English | ||
| 46012309 | 424B5 | 2026-05-14 | English | ||
| 46151278 | Regulatory Filings 2026 | 2026-05-08 | English | ||
| 43582483 | S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43582866 | 10-Q - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43481120 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 46151281 | FORM 8-K | 2026-05-04 | English | ||
| 46151286 | Major Shareholding Notification 2026 | 2026-04-30 | English | ||
| 46151283 | Major Shareholding Notification 2026 | 2026-04-28 | English | ||
| 38002356 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-04-28 | English | ||
| 33065533 | 144 - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-27 | English | ||
| 33053040 | SCHEDULE 13G/A - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-26 | English | ||
| 33001942 | ARS - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-03-20 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Innate Pharma
Clinical-stage biotech developing immunotherapies for cance…
|
IPH | FR | Manufacturing |
|
Inner Mongolia Furui Medical Science Co.,Ltd.
Specializes in integrated diagnosis and treatment of chroni…
|
300049 | CN | Manufacturing |
|
InnoCan Pharma Corporation
Pharmaceutical tech company focused on innovative cannabino…
|
INNO | CA | Manufacturing |
|
InnoCare Pharma Limited
Developing and commercializing innovative drugs for cancer …
|
9969 | KY | Manufacturing |
|
INNOCARE PHARMA LIMITED
Develops molecularly targeted therapies for cancer and auto…
|
688428 | CN | Manufacturing |
|
INNOGENE Co., Ltd.
Develops and distributes anti-aging products for skin regen…
|
344860 | KR | Manufacturing |
|
INNOVA CAPTAB LIMITED
Integrated pharmaceutical CDMO specializing in R&D, manufac…
|
INNOVACAP | IN | Manufacturing |
|
Innovent Biologics, Inc.
Develops and commercializes innovative biopharma drugs for …
|
1801 | KY | Manufacturing |
|
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD.
Provides IVD reagents and clinical instruments for rapid di…
|
688253 | CN | Manufacturing |
|
INOVIO PHARMACEUTICALS, INC.
A clinical-stage biotech firm developing DNA medicines deli…
|
INO | US | Manufacturing |
GILEAD SCIENCES, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29828/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29828 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29828 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29828 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29828}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GILEAD SCIENCES, INC. (id: 29828)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.